Baidu
map

Nature:RIPK1剪切异常会引起自身炎症性疾病

2019-12-14 海北 MedSci原创

最近,研究人员发现,在人类细胞中,杂合的错义突变D324N,D324H和D324Y可以阻止RIPK1的半胱天冬酶裂解,并导致早发性周期性发热综合征和严重的间歇性淋巴结病,研究人员将这种情况称为“抗裂解性RIPK1诱导的自体炎症综合征”。

RIPK1是先天性免疫信号通路的关键调节因子。为了确保最佳的炎症反应,RIPK1被翻译后修饰所调节,包括已被广泛研究的泛素化和磷酸化事件,以及caspase-8介导的剪切。

尽管人们认为这种剪切事件会抑制RIPK3的激活和坏死,但至今为止,其在生理上的相关性仍不清楚。

最近,研究人员发现,在人类细胞中,杂合的错义突变D324N,D324H和D324Y可以阻止RIPK1的半胱天冬酶裂解,并导致早发性周期性发热综合征和严重的间歇性淋巴结病,研究人员将这种情况称为“抗裂解性RIPK1诱导的自体炎症综合征”。

为了定义这种疾病的机制,研究人员制作了抗裂解的Ripk1D325A突变小鼠品系。 研究人员发现,Ripk1-/-小鼠会死于全身性炎症,而Ripk1D325A / D325A小鼠则在胚胎发生过程中死亡。Casp8和Ripk3的联合缺失可以完全防止胚胎致死,但Ripk3或Mlkl的单独缺失则不能。

RIPK1激酶活性的丧失也阻止了Ripk1D325A / D325A的胚胎致死性,但是这些小鼠在断奶之前会因为依赖RIPK3的方式,发生多器官炎症而死亡。

一致的是,Ripk1D325A / D325A和Ripk1D325A / +的细胞对依赖RIPK3的TNF诱导的细胞凋亡和坏死病敏感。

杂合的Ripk1D325A / +小鼠是可以存活的,并且完全正常,但对体内的炎症刺激会产生过度反应。

因此,这些结果表明,胱天蛋白酶介导的RIPK1剪切在胚胎发育过程中十分重要,RIPK1的胱天蛋白酶的剪切不仅抑制了坏死病,而且在整个生命过程中都保持了炎症稳态。


原始出处:

Najoua Lalaoui et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseNature, 2019; DOI: https://doi.org/10.1038/s41586-019-1828-5


本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2020-10-07 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2020-06-23 huiwelcome
  6. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1884051, encodeId=0e5518840510b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 09:12:00 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055155, encodeId=5a732055155fa, content=<a href='/topic/show?id=c08c8636548' target=_blank style='color:#2F92EE;'>#自身炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86365, encryptionId=c08c8636548, topicName=自身炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sun Sep 20 23:12:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2055459, encodeId=1fe0205545960, content=<a href='/topic/show?id=0ad78636442' target=_blank style='color:#2F92EE;'>#自身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86364, encryptionId=0ad78636442, topicName=自身炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Thu Mar 19 07:12:00 CST 2020, time=2020-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736820, encodeId=1c591e36820f1, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Tue Jun 02 12:12:00 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699168, encodeId=c8281699168de, content=<a href='/topic/show?id=a5d9154938d' target=_blank style='color:#2F92EE;'>#RIPK1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15493, encryptionId=a5d9154938d, topicName=RIPK1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20729916530, createdName=huiwelcome, createdTime=Tue Jun 23 12:12:00 CST 2020, time=2020-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547288, encodeId=ac82154e28831, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Dec 16 06:12:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376953, encodeId=40b83e695334, content=新的进展,好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sat Dec 14 20:27:45 CST 2019, time=2019-12-14, status=1, ipAttribution=)]
    2019-12-14 njwbhuang

    新的进展,好文章!

    0

Baidu
map
Baidu
map
Baidu
map